Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal women.

Endocr Relat Cancer · 2012 · PMC3322660 · PMID 22199143

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

ERα bioactivity was independently associated with breast cancer after adjustment for all hormones and AR and borderline significant after adjustment for ERβ for those women who had given a sample >2 years before diagnosis.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.